Patenting in the Indian Pharmaceutical Industry: a Post TRIPS Analysis
نویسندگان
چکیده
The Pharmaceutical Industry witnessed a change after the formation of World Trade Organization (WTO) in 1995 when India, being a signatory member of WTO, adopted Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement. Indian pharmaceutical industry, being a highly fragmented one and dominated mostly by a large number of smaller enterprises, was also apprehensive when TRIPS was included in WTO. In the above backdrop, this paper examines the Impact of TRIPS on Research and Development, Exports and Patenting activity of The Pharmaceutical Industry of India. The results of the study highlight an increase in R & D Expenses, and R& D Intensity of leading Pharmaceutical companies in the PostTRIPs period. Moreover, the Indian companies have been at the forefront, both in terms of Drug Master Filings (DMF) and abbreviated New Drug Applications (ANDA) filings in post TRIPS period.
منابع مشابه
Patenting and R&D in Indian Pharmaceutical Industry: Post-TRIPS Scenario
This paper studies the impact of a restructured patent regime on the R&D expenditure and the patenting activity of Indian pharmaceutical companies. The results indicate that there is an increase in both R&D investment and measured inventive output in the form of patents. The firms, which have paid very little attention to research and innovation in the past, are responding to the restructured I...
متن کاملPatent or Perish : Is the Indian Pharmaceutical Sector Geared up for the New Stronger Patenting Regime ?
The Uruguay Round of Trade Negotiations in April 1994 and the establishment of the World Trade Organization (WTO) in January 1995, raised many questions regarding India’s participation in the world trade, its integration with the world economy and the likely costs and benefits from this integration. In the light of this, the present paper tries to access India’s patenting activities in relation...
متن کاملWith the help of a foreign ally: biopharmaceutical innovation in India after TRIPS.
This article investigates the implications of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), which reached full-fledged implementation in 2005, for the patenting activity of Indian biopharmaceutical companies. The Indian biopharmaceutical industry is well-known for its generic producers, whose business models capitalize on the opportunity to reverse-engineer pat...
متن کامل2 . 1 Literature Review on Pharmaceutical Industry
Alka Chadha (2008) This paper studies the impact of the strict patent regime on the patenting activity of Indian pharmaceutical firms and finds that patenting activity of these firms has increased after the signing of TRIPs. The study is conducted for 65 pharmaceutical firms for the period 1991 to 2004 using different parametric and semiparametric count panel data models. Results across differe...
متن کاملIndian Institute of Management Calcutta
R&D expenditure has dramatically increased for a segment of the Indian pharmaceutical industry since around the mid-1990s when TRIPS came into effect. It is not only that the amount of R&D expenditure has gone up. There has also been a change in the structure of R&D activities of the Indian companies. While in the past they were primarily engaged with development of new processes for manufactur...
متن کامل